Molecularly Matched Therapy and Outcomes in End-Stage Cancers
Lead Acredit professors Anne Hansen Ree and Kjersti Flatmark have published a paper outlining the final results from the MetAction
Read more
Research
Neoadjuvant chemotherapy and intratumoral T-cell density
Acredit’s Vegar Johansen Dagenborg has published a paper called “Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell
Read more
Immunogenic response with in MOC31PE
In a new study titled “Immune stimulatory effect of anti-EpCAM immunotoxin – improved overall survival of metastatic colorectal cancer patients”,
Read more
ICD via Oxaliplatin and Radiation
ACREDIT’s own Dr Simer Jit Bains has published a new paper looking into immune response in patients undergoing neoadjuvant oxaliplatin
Read more
Sex Differences in Metastatic Rectal Cancer
A new paper entitled “Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?” authored by Sebastian
Read more
Conversion of CLM using HAI
A new paper has been published by ACREDIT’s Dr Hanna Abrahamsson looking into the conversion of primarily unresectable liver metastases
Read more
Intraperitoneal Mitomycin C Improves Survival in PMP
Acredit co-founder Professor Kjersti Flatmark and colleagues have published new findings showing that the use of mitomycin C with intraperitoneal
Read moreLaparoscopic versus open liver resection
Drs Davit Aghayan and Åsmund Fretland have released new research showing that the use of laparoscopic surgery for patients with
Read more
miR-141-3p and miR-375 in Metastatic Rectal Cancer
Acredit members Sebastian Meltzer and Tonje Bjørnetrø have recently published a new paper describing the potential for use of miR-141-3p
Read more
Circulating Vitamin D May Lower Risk of Metastatic Progression
Acredit’s Hanna Abrahamsson has published a paper showing that high-risk rectal cancer patients with higher levels of circulating vitamin D
Read more